| Factor Information | |
|---|---|
| Data ID | 1707 |
| Factor | PATD(pulmonary artery trunk diameter) (mm) |
| Description | compared with the CHD group, the PH-CHD group had higher PASP, PADP, RVSP, mPAP, RVDT, and PAD. |
| Biomarker | NA |
| Classification | E11 (physiological factor - physical sign) |
| Association | |
|---|---|
| Application | diagnosis |
| Objective | This study aims to estimate plasma levels of acylated ghrelin in children with pulmonary hypertension (PH) associated with congenital heart disease (CHD) and to correlate the levels of acylated ghrelin with endothelin-1 (ET-1), nitric oxide (NO), and clinical hemodynamic parameters. |
| Conclusion | Compared with the CHD group, the PH-CHD group had higher PASP, PADP, RVSP, mPAP, RVD, and PAD. |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 548 |
| CHD Type | isolated CHD |
| CHD Subtype | VSD/ASD/PDA/other |
| Reference | |
|---|---|
| PMID | 25981561 |
| Year | 2015 |
| Title | Plasma Levels of Acylated Ghrelin in Children with Pulmonary Hypertension Associated with Congenital Heart Disease |
| Sample | ||
|---|---|---|
| Population | children | |
| Source | blood | |
| Region | Luzhou, China | |
| Method | N/A | |
| Race | Asian | |
| Disease History | N/A | |
| Treatment History | right heart catheterization | |
| Group | CHD-PAH children(Treatment) | CHD chlidren(Control) |
| Number | 20 | 20 |
| Age | 35.9 ± 20.9 months | 36.2 ± 17.9 months |
| Gender (Male: Female) | 13:7 | 11:9 |
| Marker Level | 16.4 ± 1.8 mm | 14.0 ± 1.5 mm |
